SEC Tracker
Get the app
APYX · XBRL financial data

Apyx Medical financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (APYX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers11,97614,662*10,24412,14911,48714,222*9,43011,37312,87719,164*12,49013,884
Cost of goods and services sold3,9985,733*4,2954,6564,5335,258*3,7654,2904,5807,165*4,5655,014
Gross profit7,9788,929*5,9497,4936,9548,964*5,6657,0838,29711,999*7,9258,870
Research and development1,2761,248*1,3971,4241,1421,117*804824801944*765793
Selling, general and administrative4,8416,724*4,8974,8384,2914,832*3,3824,1403,6564,625*3,5765,285
Total operating expenses12,61514,705*12,56413,04010,58912,012*8,7169,6579,12911,988*8,83610,676
Other operating income (expense)(19)0*(21)(1)24(163)*007616*362
Operating income (loss)(4,637)(5,776)*(6,615)(5,547)(3,635)(3,048)*(3,051)(2,574)(832)11*(911)(1,806)
Interest income248443*495439378294*304278292234*244250
Interest expense5851,116*1,3961,4271,4311,653*1,3761,3931,4131,407*1,3691,394
Other income (expense)(356)(3,761)*(922)(989)24(163)*00————
Income tax expense (benefit)(318)87*53506089*49497894*143124
Net income (loss)(4,629)(9,607)*(7,576)(6,556)(4,703)(4,628)*(4,150)(3,778)(1,984)(1,299)*(2,108)(3,243)
Earnings per share, basic USD per share(0.13)(0.28)*(0.22)(0.19)(0.14)(0.12)*(0.10)(0.09)(0.05)(0.03)*(0.05)(0.07)
Earnings per share, diluted USD per share(0.13)(0.28)*(0.22)(0.19)————————
Weighted average shares, basic thousands of shares34,64234,644*34,64434,64434,64438,216*40,72940,72940,74842,162*43,74243,850
Weighted average shares, diluted thousands of shares34,64234,644*34,64434,644————————

Balance sheet

CSV

Fiscal quarters (APYX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents22,13443,65237,28232,67828,01331,74131,01129,30125,13531,74031,13727,617
Accounts receivable12,64814,02312,48712,70913,03615,48011,64511,24812,99516,77612,75513,614
Inventory11,2859,9239,7959,3249,0007,5647,6858,1929,1458,6029,53610,747
Prepaid and other current assets3,4872,7342,3621,9602,1091,6551,5101,1741,5131,3531,3671,177
Total current assets50,15070,36261,92656,67152,15856,44051,85149,91548,78858,47154,79553,155
Property and equipment, net2,0931,9151,7791,9181,9051,9871,9102,0482,3902,3712,2352,110
Right-of-use asset5,2745,1625,0494,9354,8204,7034,5844,4644,3424,2184,0924,014
Total assets59,44679,24070,71165,39460,72164,84260,16058,18857,36566,84063,02561,072
Accounts payable2,0502,7122,1032,3481,9142,6152,3052,8933,2203,0582,6292,190
Accrued liabilities—9,661——7,2917,7516,8317,2757,3448,2146,3776,692
Total current liabilities10,29412,74010,55610,6399,55510,7219,51010,56610,97811,7009,4479,354
Long-term debt9,00933,18533,40633,62833,85333,89334,12734,36534,60734,84935,08735,328
Lease liability, non-current4,9924,8964,7954,6974,6064,4834,3874,2924,1734,0513,9263,828
Total liabilities25,86052,31850,25150,47049,52450,50749,51650,73251,28552,00949,93749,982
Accumulated deficit(44,841)(54,448)(62,024)(68,580)(73,283)(77,911)(82,061)(85,839)(87,823)(89,122)(91,230)(94,473)
Total stockholders' equity33,34826,70120,25314,74711,04114,21010,5117,2535,84814,54012,83210,663
Total liabilities and equity59,44679,24070,71165,39460,72164,84260,16058,18857,36566,84063,02561,072
Common shares outstanding (cover page) thousands of shares34,64434,64434,64434,64434,64437,79437,79437,81938,24241,82941,87442,124

Cash flows

CSV

Fiscal quarters (APYX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(4,629)(9,607)*(7,576)(6,556)(4,703)(4,628)*(4,150)(3,778)(1,984)(1,299)*(2,108)(3,243)
Stock-based compensation1,351*914*1,1281,050*997*838*451520*530*500*3121,074*
Depreciation and amortization186*152*157156*144*142*138132*164*221*202196*
Net cash from operating activities3,696*(2,212)*(6,341)(4,329)*(4,440)*(2,937)*(702)(1,233)*(3,536)*(2,530)*(572)(3,490)*
Purchases of property and equipment174*93*35289*153*245*55265*519*275*6066*
Net cash from investing activities(174)*(93)*(35)(289)*(153)*(245)*(55)(265)*(519)*(275)*(60)(66)*
Proceeds from long-term debt0*34,185*00*0*0*——————
Net cash from financing activities164*23,844*(5)(5)*(5)*6,760*2525*45*9,485*83(5)*
Net change in cash3,655*21,518*(6,370)(4,604)*(4,665)*3,728*(730)(1,710)*(4,166)*6,605*(603)(3,520)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Apyx Medical27,61713,884(3,490)*42.1M7.9 quarters 10-QJun 30, 2026
Venus Concept4,31213,776(4,890)*1.9M0.9 quarters 10-QSep 30, 2025
Mobia Medical177,09013,505(15,670)*33.3M11.3 quarters 10-QJun 30, 2026
Lucid Diagnostics33,404not reported(11,297)*203.2M3.0 quarters 10-QJun 30, 2026
TELA Bio30,42419,291(9,381)*44.9M3.2 quarters 10-QJun 30, 2026
enVVeno Medical2,585not reported(3,178)*694,8265.6 quarters 10-QSep 30, 2026
Accuray40,623100,919*2,427*119.4M— 10-KJun 30, 2026
Spectral AI14,0003,524(4,097)*32.2M3.4 quarters 10-QJun 30, 2026
Sensus Healthcare15,1862,290(3,133)*16.5M4.8 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.